Literature DB >> 29886172

LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO.

Xinhong Pei1, Xinxing Wang1, Huixiang Li2.   

Abstract

OBJECTIVE: To investigate the mechanism of lncRNA SNHG1 in the immune escape of breast cancer (BC).
METHODS: SNHG1, miR-448 and IL-10 levels were evaluated by qRT-PCR. The protein levels of IDO and Foxp3 were measured by Western blot. SNHG1 and miR-448 interaction was tested by RIP assay and RNA pull-down assay. MiR-448 and IDO interaction was observed by luciferase reporter assay.
RESULTS: Compared with CD4+T cells, miR-448 expression in CD4+ TIL cells was decreased, while the expression of SNHG1, IDO, IL-10 and Foxp3 were increased. Moreover, SNHG1 directly contacted with miR-448, which could negatively regulate IDO. In cells treated with siRNA-SNHG and miR-448 inhibitor, interference SNHG1 up-regulated miR-448 expression and down-regulated IDO expression, while miR-448 inhibitor reversed this effect. In addition, miR-448 inhibitor reversed the inhibitory effect of siRNA-SNHG1 on Treg cell differentiation, and siRNA-SNHG1 could reduce tumor volume and down-regulated the expressions of SNHG1, IL-10, IDO and Foxp3.
CONCLUSION: Interference SNHG1 could inhibit the differentiation of Treg cells by promoting miR-448 expression and reducing IDO level, thereby impeding the immune escape of BC.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; IDO; SNHG1; Treg cell; miR-448

Mesh:

Substances:

Year:  2018        PMID: 29886172     DOI: 10.1016/j.ijbiomac.2018.06.033

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  70 in total

Review 1.  Tumor immune microenvironment lncRNAs.

Authors:  Eun-Gyeong Park; Sung-Jin Pyo; Youxi Cui; Sang-Ho Yoon; Jin-Wu Nam
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

2.  A Prognostic Signature of Glycolysis-Related Long Noncoding RNAs for Molecular Subtypes in the Tumor Immune Microenvironment of Lung Adenocarcinoma.

Authors:  Na Li; Mu Su; Louyin Zhu; Li Wang; Yonggang Peng; Bo Dong; Liya Ma; Yongyu Liu
Journal:  Int J Gen Med       Date:  2021-11-27

3.  The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells.

Authors:  Dina Mofed; Jihad I Omran; Salwa Sabet; Ahmed A Baiomy; Marwan Emara; Tamer Z Salem
Journal:  Mol Biol Rep       Date:  2022-10-07       Impact factor: 2.742

4.  A Novel lncRNA Panel for Risk Stratification and Immune Landscape in Breast Cancer Patients.

Authors:  Chen Li; Xiaolong Wang; Tong Chen; Wenhao Li; Qifeng Yang
Journal:  Int J Gen Med       Date:  2022-05-27

5.  SNHG25 facilitates SNORA50C accumulation to stabilize HDAC1 in neuroblastoma cells.

Authors:  Huijuan Zeng; Jing Pan; Chao Hu; Jiliang Yang; Jiahao Li; Tianbao Tan; Manna Zheng; Yuanchao Shen; Tianyou Yang; Yun Deng; Yan Zou
Journal:  Cell Death Dis       Date:  2022-07-11       Impact factor: 9.685

6.  LncRNA Snhg1 Plays an Important Role via Sequestering rno-miR-139-5p to Function as a ceRNA in Acute Rejection After Rat Liver Transplantation Based on the Bioinformatics Analysis.

Authors:  Wu Wu; Menghao Wang; Chunming Li; Zhu Zhu; Yang Zhang; Di Wu; Zhibing Ou; Zuojin Liu
Journal:  Front Genet       Date:  2022-06-02       Impact factor: 4.772

Review 7.  Roles of long noncoding RNAs on tumor immune escape by regulating immune cells differentiation and function.

Authors:  Lisha Chang; Juan Li; Jie Ding; Yifan Lian; Chaonan Huangfu; Keming Wang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

Review 8.  Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.

Authors:  Yingying Xing; Guojing Ruan; Haiwei Ni; Hai Qin; Simiao Chen; Xinyue Gu; Jiamin Shang; Yantong Zhou; Xi Tao; Lufeng Zheng
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

Review 9.  Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.

Authors:  Ya-Nan Pi; Wen-Cai Qi; Bai-Rong Xia; Ge Lou; Wei-Lin Jin
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 8.786

10.  Long non-coding RNA MEG3 mediates the miR-149-3p/FOXP3 axis by reducing p53 ubiquitination to exert a suppressive effect on regulatory T cell differentiation and immune escape in esophageal cancer.

Authors:  Qi-Rong Xu; Jian Tang; Hong-Ying Liao; Ben-Tong Yu; Xiang-Yuan He; Yu-Zhen Zheng; Sheng Liu
Journal:  J Transl Med       Date:  2021-06-17       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.